Close
ACHEMA MIDDLE EAST 2026

AbbVie Launches New API Manufacturing Facility in Illinois

AbbVie has started construction of a new active pharmaceutical ingredient (API) manufacturing facility in North Chicago, Illinois, a critical milestone in its strategy to...

Amgen to Expand U.S. Manufacturing with $650M Investment

Amgen has announced a $650 million expansion of its U.S. manufacturing facilities, a development that will create almost 750 new positions. The expansion will...

Green Chemistry in Sustainable API Manufacturing

Green Chemistry Driving Sustainable API and Ingredient Production The pharmaceutical industry is at the cusp of a sustainability revolution, with green chemistry principles guiding the...

Future of Active Pharmaceutical Ingredients Supply

The Future of Active Pharmaceutical Ingredients in Global Supply Chains Globalization has fundamentally transformed the ways in which pharmaceutical companies source and manufacture active pharmaceutical...

Advances in Pharmaceutical Excipients for New Therapies

Advances in Pharmaceutical Excipients Supporting Next-Gen Therapies Pharmaceutical excipients, once deemed inert carriers, have evolved into active enablers that significantly influence drug stability, delivery, and...

API Manufacturing Quality and Regulatory Trends

Quality and Regulatory Trends Shaping API Manufacturing Standards In today’s pharmaceutical landscape, stringent quality and regulatory requirements govern every aspect of API manufacturing. As authorities...

Lilly to Build $6.5B API Manufacturing Facility in Houston

Eli Lilly and Company has unveiled plans for a $6.5 billion manufacturing facility in Generation Park, Houston, Texas. The project, described as a next-generation...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...